Search Results - "Katashima, Masataka"
-
1
Pharmacokinetics of Mirabegron, a β3 -Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects
Published in Clinical therapeutics (01-05-2015)“…Abstract Purpose The objective of these studies was to evaluate the pharmacokinetic profile, safety, and tolerability of mirabegron, a β3 -adrenoceptor agonist…”
Get full text
Journal Article -
2
Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects
Published in Clinical pharmacology in drug development (01-04-2019)“…Roxadustat is a hypoxia‐inducible factor prolyl hydroxylase inhibitor in late‐stage clinical development for the treatment of anemia in chronic kidney disease…”
Get full text
Journal Article -
3
Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females
Published in Drug metabolism and pharmacokinetics (01-12-2016)“…Mirabegron, the first selective β3-adrenoceptor agonist for the treatment of overactive bladder (OAB), inhibits cytochrome P450 isozyme CYP2D6. This study was…”
Get full text
Journal Article -
4
Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies
Published in Advances in therapy (01-12-2017)“…Introduction Amenamevir (ASP2151) is a nonnucleoside antiherpesvirus compound available for the treatment of varicella–zoster virus infections. In this article…”
Get full text
Journal Article -
5
A phase I, open-label, single-dose micro tracer mass balance study of 14C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry
Published in Drug metabolism and pharmacokinetics (01-04-2018)“…ASP7991 is a calcimimetic that acts on the calcium-sensing receptor on parathyroid cell membranes and suppresses parathyroid hormone (PTH) secretion in the…”
Get full text
Journal Article -
6
A phase I, open-label, single-dose micro tracer mass balance study of 14 C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry
Published in Drug metabolism and pharmacokinetics (01-04-2018)“…ASP7991 is a calcimimetic that acts on the calcium-sensing receptor on parathyroid cell membranes and suppresses parathyroid hormone (PTH) secretion in the…”
Get full text
Journal Article -
7
Integrative pharmacokinetic–pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes
Published in Drug metabolism and pharmacokinetics (01-08-2016)“…Amenamevir is a novel drug that targets the viral helicase–primase complex. While dose-dependent efficacy had been observed in non-clinical studies, no clear…”
Get full text
Journal Article -
8
The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies
Published in Advances in therapy (01-12-2017)“…Introduction Amenamevir (ASP2151) is a nonnucleoside human herpesvirus helicase-primase inhibitor that was approved in Japan for the treatment of herpes zoster…”
Get full text
Journal Article -
9
Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections
Published in Biological & pharmaceutical bulletin (01-08-2006)“…The objective of this study was to propose the appropriate dosage regimen of micafungin for pediatric use, considering the effects of dose-linearity, age and…”
Get full text
Journal Article -
10
Role of micafungin in the antifungal armamentarium
Published in Current medicinal chemistry (01-05-2007)“…Serious infections caused by opportunistic molds remain a major problem for public health. Immune deficiency following organ transplantation and aggressive…”
Get more information
Journal Article -
11
Japanese bioanalytical method validation guideline: the world's first regulatory guideline dedicated to ligand-binding assays
Published in Bioanalysis (01-05-2015)Get full text
Journal Article -
12
Pharmacological and clinical profile of nitisinone (Orfadin(®) Capsules): a therapeutic agent for hereditary tyrosinemia type 1
Published in Nihon yakurigaku zasshi (01-12-2015)Get more information
Journal Article -
13
Population Pharmacokinetic Analysis of Micafungin in Japanese Patients with Fungal Infections
Published in Drug metabolism and pharmacokinetics (01-01-2006)“…The object of this analysis was to develop a population pharmacokinetic model of micafungin, a new anti-fungal agent of the echinocandin class, to optimize…”
Get full text
Journal Article -
14
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study
Published in Clinical therapeutics (01-05-2020)“…This study aimed to evaluate the safety, tolerability, and pharmacokinetic and pharmacodynamic properties of ASP3652, a peripherally acting inhibitor of…”
Get full text
Journal Article -
15
Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression
Published in Clinical therapeutics (01-06-2020)“…The objectives of this study were to explore covariates of plasma quetiapine concentrations after oral administration of quetiapine extended-release…”
Get full text
Journal Article -
16
Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder
Published in Clinical therapeutics (01-08-2020)“…Quetiapine has been reported to prolong the QT interval, and has been used as a positive control in thorough QT studies. The objective of the present study was…”
Get full text
Journal Article -
17
Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males
Published in Clinical drug investigation (01-06-2021)“…Background and Objectives Beraprost sodium (BPS), an orally administrable prostaglandin I 2 derivative, is used for the treatment of chronic arterial occlusion…”
Get full text
Journal Article -
18
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function
Published in Clinical drug investigation (01-02-2020)“…Background and Objective This study measured and compared the exposure and safety of peficitinib (ASP015K), a novel oral Janus kinase inhibitor, in subjects…”
Get full text
Journal Article -
19
Analytical method validation for biomarkers as a drug development tool: points to consider
Published in Bioanalysis (01-09-2021)“…Biomarkers are an important drug developmental tool. Assessment of quantitative analytical methods of biomarkers is not included in any regulatory documents in…”
Get full text
Journal Article -
20
Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections
Published in Biological & Pharmaceutical Bulletin (2006)“…The objective of this study was to propose the appropriate dosage regimen of micafungin for pediatric use, considering the effects of dose-linearity, age and…”
Get full text
Journal Article